| NCT Number | NCT05652374 |
| Lead Sponsor | Radboud University Medical Center
Collaborators: IBSA Institut Biochimique SA, Goodlife Pharma B.V. |
| Conditions | Recurrent Urinary Tract Infection |
| Enrollment | 100 participants |
| Start Date | 2022-10-20 |
| Primary Completion | 2027-10 (estimated) |
| Study Completion | 2027-10 (estimated) |
| Updated on ClinicalTrials.gov | 2024-11-18 |